Characteristics of surgically resected non‐small cell lung cancer patients with post‐recurrence cure-Reference-Cited by-同舟云学术

Characteristics of surgically resected non‐small cell lung cancer patients with post‐recurrence cure

Published:2020-09-22 Issue:11 Volume:11 Page:3280-3288
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Sonoda Dai¹²^ORCID,Matsuura Yosuke¹,Kondo Yasuto¹²,Ichinose Junji¹,Nakao Masayuki¹,Ninomiya Hironori³,Ishikawa Yuichi³,Nishio Makoto⁴,Okumura Sakae¹,Satoh Yukitoshi²,Mun Mingyon¹

Affiliation:

1. Department of Thoracic Surgical Oncology The Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan

2. Department of Thoracic Surgery Kitasato University School of Medicine Kanagawa Japan

3. Department of Pathology The Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan

4. Department of Thoracic Medical Oncology The Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13669

Reference29 articles.

1. Long-Term Results of Combined-Modality Therapy in Resectable Non–Small-Cell Lung Cancer

2. Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer

3. Relevance of an extensive follow‐up after surgery for nonsmall cell lung cancer;Gourcerol D;Eur Respir J,2013

4. Results of Long-Term Follow-Up of Patients With Completely Resected Non-Small Cell Lung Cancer

5. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis of patients with recurrent nonsmall cell lung cancer who received the best supportive care alone;Current Problems in Surgery;2024-01

2. Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non–small cell lung cancer and mutated EGFR;Supportive Care in Cancer;2023-12-27

3. The Naples Prognostic Score Is a Useful Tool to Assess Surgical Treatment in Non-Small Cell Lung Cancer;Diagnostics;2023-12-12

4. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study;BMC Cancer;2023-11-06

5. Cost–effectiveness of adjuvant atezolizumab for patients with stage II–IIIA PD-L1+ non-small-cell lung cancer;Immunotherapy;2023-06